Log in

NASDAQ:TRPX - THERAPIX BIOSCI/S Stock Price, Forecast & News

-0.03 (-3.70 %)
(As of 01/19/2020 01:19 PM ET)
Today's Range
Now: $0.78
50-Day Range
MA: $1.13
52-Week Range
Now: $0.78
Volume55,855 shs
Average Volume126,814 shs
Market Capitalization$2.74 million
P/E RatioN/A
Dividend YieldN/A
Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include THX-110 for the treatment of Tourette syndrome, Obstructive Sleep Apnea, and pain; THX-130 for the treatment of Mild Cognitive Impairment and Traumatic Brain Injury; THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain. Therapix Biosciences Ltd. has a product development agreement with Cure Pharmaceutical to develop cannabinoid-based product for sleep disorders. The company was formerly known as NasVax Ltd. and changed its name to Therapix Biosciences Ltd. in November 2013. Therapix Biosciences Ltd. was founded in 2004 and is headquartered in Givatayim, Israel.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:TRPX



Sales & Book Value

Annual SalesN/A
Book Value$0.02 per share



Market Cap$2.74 million
Next Earnings Date5/20/2020 (Estimated)
OptionableNot Optionable

Receive TRPX News and Ratings via Email

Sign-up to receive the latest news and ratings for TRPX and its competitors with MarketBeat's FREE daily newsletter.

THERAPIX BIOSCI/S (NASDAQ:TRPX) Frequently Asked Questions

What is THERAPIX BIOSCI/S's stock symbol?

THERAPIX BIOSCI/S trades on the NASDAQ under the ticker symbol "TRPX."

How were THERAPIX BIOSCI/S's earnings last quarter?

THERAPIX BIOSCI/S (NASDAQ:TRPX) announced its earnings results on Monday, August, 20th. The company reported ($0.35) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.59) by $0.24. View THERAPIX BIOSCI/S's Earnings History.

When is THERAPIX BIOSCI/S's next earnings date?

THERAPIX BIOSCI/S is scheduled to release their next quarterly earnings announcement on Wednesday, May 20th 2020. View Earnings Estimates for THERAPIX BIOSCI/S.

Has THERAPIX BIOSCI/S been receiving favorable news coverage?

Media stories about TRPX stock have trended positive on Sunday, according to InfoTrie. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. THERAPIX BIOSCI/S earned a news sentiment score of 2.7 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for THERAPIX BIOSCI/S.

Who are some of THERAPIX BIOSCI/S's key competitors?

What other stocks do shareholders of THERAPIX BIOSCI/S own?

Who are THERAPIX BIOSCI/S's key executives?

THERAPIX BIOSCI/S's management team includes the folowing people:
  • Dr. Ascher Shmulewitz, Chairman & Interim CEO (Age 63)
  • Dr. Adi Zuloff-Shani, Chief Technology Officer (Age 51)
  • Mr. Oz Adler CPA, Chief Financial Officer (Age 32)

How do I buy shares of THERAPIX BIOSCI/S?

Shares of TRPX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is THERAPIX BIOSCI/S's stock price today?

One share of TRPX stock can currently be purchased for approximately $0.78.

How big of a company is THERAPIX BIOSCI/S?

THERAPIX BIOSCI/S has a market capitalization of $2.74 million. THERAPIX BIOSCI/S employs 9 workers across the globe.View Additional Information About THERAPIX BIOSCI/S.

What is THERAPIX BIOSCI/S's official website?

The official website for THERAPIX BIOSCI/S is http://therapixbio.com/.

How can I contact THERAPIX BIOSCI/S?

THERAPIX BIOSCI/S's mailing address is 4 Ariel Sharon Street HaShahar Tower 16th Floor, Givatayim L3, 5320047. The company can be reached via phone at 972-3616-7055 or via email at [email protected]

MarketBeat Community Rating for THERAPIX BIOSCI/S (NASDAQ TRPX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  223 (Vote Outperform)
Underperform Votes:  209 (Vote Underperform)
Total Votes:  432
MarketBeat's community ratings are surveys of what our community members think about THERAPIX BIOSCI/S and other stocks. Vote "Outperform" if you believe TRPX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRPX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/19/2020 by MarketBeat.com Staff

Featured Article: What is a Tariff?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel